Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
0.32
Aug. 21, 2025 13:56:36- Change -0.003 (-0.91715%)
- Volume 898,076
- Today's Open 0.3227
- Previous Close 0.3271
- Today's High 0.3365
- Today's Low 0.32
- 52 Week High 4.3
- 52 Week Low 0.32